LOGO
LOGO

Corporate News

Anterix Stock Jumps 26% On Strategic Review Announcement

By RTTNews Staff Writer   ✉   | Published:   | Follow Us On Google News
rttnewslogo20mar2024

Anterix Inc. (ATEX) is up 25.30 percent, gaining $7.22 to trade at $35.74. The surge follows the company's announcement that it has engaged Morgan Stanley to support a formal strategic review process amid growing interest in its business.

Anterix also unveiled a new initiative to accelerate the deployment of 900 MHz private networks, drawing strong interest from the sector.

ATEX is currently trading at $35.74, up from the previous close of $28.52. The stock has moved between $35.25 and $39.72 in today's session. Trading volume has surged to 575,833 shares, far exceeding the average volume of 117,781.

The stock remains within its 52-week range of $27.37 to $42.41, as investors respond positively to the company's strategic review and industry engagement efforts.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Global Economics Weekly Update - May 04 – May 08, 2026

May 08, 2026 15:50 ET
Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.

Latest Updates on COVID-19